This meeting took place in 2015


Here are the related meetings in 2020:
Tumor Metabolism (C2)

For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.

Integrating Metabolism and Tumor Biology (J1)


Organizer(s) Ralph J. DeBerardinis, Robert T. Abraham and Eyal Gottlieb
January 13—18, 2015
Fairmont Hotel Vancouver • Vancouver, British Columbia Canada
Discounted Abstract Deadline: Sep 24, 2014
Abstract Deadline: Oct 16, 2014
Scholarship Deadline: Sep 24, 2014
Discounted Registration Deadline: Nov 13, 2014

Sponsored by Astellas Pharma Inc., Bayer HealthCare Pharmaceuticals, Cell Signaling Technology, Inc., ImmunoGen, Inc., Pfizer Inc. and Takeda Pharmaceutical Company


Summary of Meeting:
Work in recent years has demonstrated extensive interconnectivity between oncogenic signaling pathways and intermediate metabolism. Compelling evidence indicates that signaling aberrations that drive oncogenesis trigger extensive alterations in metabolic flux; conversely, mutational alterations in certain metabolic enzymes are capable of priming cells for malignancy. These observations have raised hopes that understanding the metabolic underpinnings of cellular transformation, tumor growth and metastasis will result in more effective strategies to diagnose and treat cancer. Current challenges include understanding how best to translate observations from simple models of tumor cell growth to bona fide tumors in vivo, and understanding which aspects of dysregulated cell metabolism contribute to tumor maintenance and progression. This conference will bring together scientists from academia and industry attacking this problem on many levels. A major theme of the meeting will be exploring the cross-talk between metabolism and various other dimensions of systems biology, including epigenetics, protein function, stress responses and signal transduction. Emerging principles regarding the influence of the tumor microenvironment on cellular metabolism will be discussed in detail, as will new progress toward exploiting metabolic reprogramming to image and treat cancer. The meeting is paired with one on “PI 3-Kinase Signaling Pathways in Disease,” providing a fertile environment for exchange of ideas between these two highly connected fields.

View Meeting Program

Scholarships/Awards

National Institute of General Medical Sciences (NIGMS) Ancillary Training Program Scholarship Recipients

Christopher Thomas Hensley
University of Texas Southwestern Medical Center, USA

Erica L. Sanchez
University of Washington, USA

Mark A. White
University of Houston, USA

National Cancer Institute (NCI) Scholarship Recipients

Cyril Corbet
Université Catholique de Louvain, Belgium

Dohoon Kim
University of Massachusetts Medical School, USA

Bo Li
Sun Yat-sen University, China

Christine A. Parachoniak
Massachusetts General Hospital Cancer Center, USA

Saverio Tardito
Beatson Institute for Cancer Research, Scotland

The Elkes Foundation Scholarship Recipients

Jonathan L. Coloff
University of Illinois at Chicago, USA

John C. Schell
University of Utah, USA